Cas 873948-07-3,Piperidine, 2-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-5-nitro-2-phenyl- , (2S,5S)-

873948-07-3

Post Buying Request

Basic information

Product Name: Piperidine, 2-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-5-nitro-2-phenyl- , (2S,5S)-
Synonyms:
CAS NO:873948-07-3
Molecular Formula: C22H22F6N2O3
Molecular Weight: 476.419
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Piperidine, 2-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-5-nitro-2-phenyl- , (2S,5S)-(CAS DataBase Reference)
NIST Chemistry Reference: Piperidine, 2-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-5-nitro-2-phenyl- , (2S,5S)-(873948-07-3)
EPA Substance Registry System: Piperidine, 2-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-5-nitro-2-phenyl- , (2S,5S)-(873948-07-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 873948-07-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

873948-07-3 Suppliers

Recommended suppliers

873948-07-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 873948-07-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,3,9,4 and 8 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 873948-07:
(8*8)+(7*7)+(6*3)+(5*9)+(4*4)+(3*8)+(2*0)+(1*7)=223
223 % 10 = 3
So 873948-07-3 is a valid CAS Registry Number.

873948-07-3Upstream product

873947-63-8 benzyl (2S)-2-({(1R)-1-[3,5-bis(tri-fluoro-methyl)-phenyl]ethoxy}-methyl)-5-nitro-2-phenylpiperidine-1-carboxylate

873948-07-3Downstream Products

873948-07-3Relevant academic research and scientific papers

BRIDGED RING NK1 ANTAGONISTS

-

Page/Page column 82-83, (2010/11/08)

A compound having the general structure shown in Formula (I): or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK1 receptors, for example various physiological disorders, symptoms or di

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 873948-07-3